Press release: Results from new trial of the candidate TB vaccine MTBVAC offer hope for control of tuberculosis in infants

Press release: Results from new trial of the candidate TB vaccine MTBVAC offer hope for control of tuberculosis in infants

First trial of a new live attenuated Mycobacterium tuberculosis vaccine in infants

Results published in The Lancet Respiratory Medicine on 12 August 2019

Comment published  in The Lancet Respiratory Medicine on 12 August 2019